Golcadomide in Combination With Rituximab for the Treatment of Patients With Relapsed or Refractory Mantle Cell Lymphoma (clinicaltrials.gov) - Oct 23, 2026 - P1/2 | N=58 | Recruiting | Sponsor: City of Hope Medical Center | Not yet recruiting ➔ Recruiting
Enrollment open • Hematological Malignancies • Lymphoma • Mantle Cell Lymphoma • Oncology
|